Home
 Portfolio Manager
 Fund
 Equities
 ETF
 Insurance Linked Funds
 Fund Tools
 Fund Selector
 Funds to Explore
 Category Quickrank
 Guaranteed Funds
 
Snapshot
Chart
Total Return
Portfolio
Rating & Risk
Management
Fees
Franklin Biotechnology Discovery Fund A(acc)CHF-H1
Performance History
2019-12-31
Growth of $10,000 (USD)
 
  • Fund
  • -20.76
  • 18.84
  • -19.94
  • 31.16
  • +/-Cat
  • -1.27
  • -1.91
  • -6.59
  • -
  • +/-Idx
  • -
  • -
  • -
  • -
 
 
 
Category: Other Equity
Index:
 
 
  • Trailing Returns(%)
  • 2020-01-24
  • YTD Return
  • -3.40
  • 1 Year
  • 15.41
  • 3 Years Annualised
  • 7.66
  • 5 Years Annualised
  • 0.57
Benchmarks
Fund Benchmark
NASDAQ Biotechnology PR USD
Morningstar Benchmark
 
Key Stats
  • Morningstar Category
  • Morningstar Rating™
  • Other Equity
  • CPF Included
  • CPF Account Type
  • No
  • Not Registered
  • CPF Risk Classification
  • CPF Focus
  • -
  • ISIN
  • Inception Date
  • LU0959058974
  • 2013-08-16
  • NAV(2020-01-24)
  • Day Change
  • CHF 15.36
  • -2.23%
  • Bid Price
  • Offer Price
  • -
  • -
  • Total Net Assets (Mil)
    (2019-12-31)
  • Total Expense Ratio
    (2019-06-30)
  • USD 1,641.01
  • 1.82 %
  • Front Load Fee(Max)
  • Redemption Fee
  • 5.75 %
  • -
  • Manager Name
  • Start Date
  • Evan S. McCulloch
  • 2000-11-01
  • Steven Kornfeld
  • 2015-09-15
  • Wendy Lam
  • 2018-09-01
Advertisement
Investment Objective: Franklin Biotechnology Discovery Fund A(acc)CHF-H1
 
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Portfolio Profile for Franklin Biotechnology Discovery Fund A(acc)CHF-H1
2019-12-31
  • Morningstar Style Box
  • Asset Allocation %
  •  
  • % Long
  • % Short
  • % Net Asset
  • Stock
  • 98.48
  • -
  • 98.48
  • Bond
  • 0.00
  • -
  • 0.00
  • Cash
  • 0.68
  • -
  • 0.68
  • Other
  • 0.84
  • -
  • 0.84
  • Top 5 Regions
  • %
  • United States
  • 90.15
  • United Kingdom
  • 3.53
  • Eurozone
  • 3.45
  • Canada
  • 1.95
  • Europe - ex Euro
  • 0.92
  • Top 5 Sectors
  • %
  • Healthcare
  • 98.48
  • Top 5 Holdings
  • Sector
  • % Net Asset
  • Amgen Inc
  • Healthcare
  • 7.04
  • Vertex Pharmaceuticals Inc
  • Healthcare
  • 6.58
  • Gilead Sciences Inc
  • Healthcare
  • 5.63
  • Illumina Inc
  • Healthcare
  • 4.97
  • Biogen Inc
  • Healthcare
  • 4.79